Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. März 2026 12:00 ET | Quelle: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/16/2026.
05. März 2026 08:27 ET | Quelle: Bernstein Liebhard LLP

VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
03. März 2026 08:23 ET | Quelle: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN)

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
02. März 2026 12:00 ET | Quelle: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/16/2026.
26. Februar 2026 12:00 ET | Quelle: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 16, 2026.
26. Februar 2026 08:34 ET | Quelle: Bernstein Liebhard LLP

VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
24. Februar 2026 08:22 ET | Quelle: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN)

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
23. Februar 2026 12:00 ET | Quelle: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 16, 2026.
19. Februar 2026 12:00 ET | Quelle: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 16, 2026.
19. Februar 2026 08:54 ET | Quelle: Bernstein Liebhard LLP

VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit

Nächste Seite